Skip to content

Study on the prevalence, associated factors and prognosis of frailty in patients with Sjogren's syndrome

Study on the prevalence, associated factors and prognosis of frailty in patients with Sjogren's syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105300
Enrollment
Unknown
Registered
2025-07-01
Start date
2024-03-18
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's syndrome

Interventions

frailty and non-frailty:NA

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with primary Sjogren's syndrome according to the revised SS international classification standards in the United States and Europe in 2002 or the pSS classification standards developed by the American Society of Rheumatology (ACR)/European Union Against Rheumatology (EULAR) in 2016; 2. First hospitalization due to diagnosis or active illness. 3. Age and gender are not limited. 4. Voluntarily participate in this study and sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1. Secondary Sjogren's syndrome; 2. Severe disability or dementia, unable to cooperate with frailty assessment or unable to communicate effectively; 3. Malignant tumors during the active period of malignant tumors or within the past 5 years; 4. Refusing to sign informed consent form.

Design outcomes

Primary

MeasureTime frame
Frailty incidence rate;Inflammatory indicators (erythrocyte sedimentation rate, C-reactive protein, interleukin-6);Ability to engage in daily activities;Locomotion;Cognitive Function;

Countries

China

Contacts

Public ContactTian Zhen

Xuanwu Hospital Capital Medical University

tian_zhen@xwhosp.org+86 10 83198497

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026